Share price: 121.16p

Director/PDMR Shareholding

20th June 2019

The Group announces that, on 20 June 2019, certain directors and persons discharging managerial responsibilities (PDMRs) of the Group exercised 10p options over a total of 965,000 ordinary shares of 10 pence each (“Ordinary Shares”) pursuant to the Group’s PSP Option Scheme 2010, and subsequently sold 600,100 Ordinary Shares at a price of 126.6 pence per Ordinary Share. Details of the option exercises, share sales and resultant shareholdings are set out below:

 

Name

Title

Options exercised

Ordinary Shares
sold

Resultant holding

Percentage of issued share capital

Mark Scott

Chief Executive

450,000

265,500

1,649,975

1.5%

Mark Bentley

Finance Director

220,000

129,800

532,718

0.5%

Stephen Highley

COO

220,000

129,800

2,226,304

2.1%

Andy Brown

Deputy Finance Director

75,000

75,000

6,160

0.01%

 

The new Ordinary Shares have been issued pursuant to the Group’s existing block listing and, as at 20 June 2019, Cello’s issued share capital comprises 106,530,309 Ordinary Shares, of which 453,000 Ordinary Shares are held in treasury. The Group’s total number of voting rights is therefore 106,077,309 Ordinary Shares, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Group under the FCA’s Disclosure Guidance and Transparency Rules.

This announcement contains inside information.

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150